Late De Novo Minimal Change Disease in a Renal Allograft

被引:0
|
作者
Madhan, Krishan K. [1 ]
Temple-Camp, Cynric R. E. [2 ]
机构
[1] Taranaki Dist Hlth Board, Renal Unit, Private Bag 2016, New Plymouth 4321, New Zealand
[2] Medlab Cent, Anat Pathol, Palmerston North, New Zealand
关键词
Kidney Allograft; Transplantation; Nephrotic Syndrome; De novo Minimal change Disease;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Among the causes of the nephrotic syndrome in renal allografts, minimal change disease is a rarity with only few cases described in the medical literature. Most cases described have occurred early in the post-transplant course. There is no established treatment for the condition but prognosis is favorable. We describe a case of minimal change disease that developed 8 years after a successful transplantation of a renal allograft in a middle-aged woman. The nephrotic syndrome was accompanied by deterioration of allograft function. Treatment with mycophenolate mofetil was successful in inducing remission and stabilizing allograft function.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 50 条
  • [41] NFAT-regulated gene expression in de novo renal allograft recipients
    Sommerer, C.
    Zeier, M.
    Meuer, S.
    Giese, T.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 476 - 476
  • [42] Incidence and clinical course of de-novo malignancies in renal allograft recipients
    Winkelhorst, JT
    Brokelman, WJ
    Tiggeler, RG
    Wobbes, T
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (04): : 409 - 413
  • [43] De novo fibrillary glomerulopathy in the renal allograft of a patient with systemic lupus erythematosus
    Isaac, J
    Herrara, GA
    Shihab, FS
    NEPHRON, 2001, 87 (04): : 365 - 368
  • [44] De Novo AL amyloidosis in renal allograft - case report and literature review
    Bulan, Batuhan
    Kucukyurt, Selin
    Karaca, Cebrail
    Murt, Ahmet
    Salihoglu, Ayse
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S211 - S211
  • [45] DE NOVO IMMUNOTACTOID GLOMERULOPATHY (ITG) IN A RENAL ALLOGRAFT: A CASE REPORT.
    Singapuri, Salman
    Tata, Sudha
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (04) : A102 - A102
  • [46] A De Novo Case of C1q Nephropathy in a Renal Allograft
    Appelbaum, Zachary
    Jagadeesan, Muralidharan
    Melancon, Joseph K.
    Shankaranarayanan, Divya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 678 - 678
  • [47] De Novo DSA in the Setting of Stable Renal Allograft Function is a Benign Finding
    Knight, Richard
    Eagar, Todd
    Duc Nguyen
    Graviss, Edward
    Kuten, Samantha
    Patel, Samir
    Moore, Linda
    Gaber, Osama
    TRANSPLANTATION, 2018, 102 : S39 - S39
  • [48] Reduction in De Novo HLA Antibodies Improves Renal Allograft Survival.
    Everly, Matthew J.
    Rebellato, Lorita M.
    Ozawa, Mikki
    Briley, Kimberly P.
    Catrou, Paul G.
    Haisch, Carl E.
    Terasaki, Paul I.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 309 - 310
  • [49] Minimal residual disease in adults with de novo AML.
    Wormann, B
    Konemann, S
    Grove, D
    Toepker, S
    Sauerland, AHB
    Buchner, T
    Hiddemann, W
    Terstappen, LWMM
    BLOOD, 1995, 86 (10) : 1313 - 1313
  • [50] De novo Membranous Nephropathy in an Allograft
    Gowrishankar, Swarnalata
    INDIAN JOURNAL OF TRANSPLANTATION, 2021, 15 (03) : 284 - 285